Arthur P Bertolino

Suggest Changes
Learn More
OBJECTIVE To evaluate the efficacy and safety of secukinumab, a fully human, anti-interleukin (IL)-17A monoclonal antibody, in patients with psoriatic arthritis (PsA). METHODS 42 patients with(More)
  • 1